Boston Scientific Corporation (FRA:BSX)

Market Cap	116.75B -15.9%
Revenue (ttm)	16.49B +21.6%
Net Income	2.38B +55.7%
EPS	1.59 +54.7%
Shares Out	n/a
PE Ratio	49.08
Forward PE	27.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Average Volume	41
Open	76.60
Previous Close	77.00
Day's Range	76.60 - 77.20
52-Week Range	74.20 - 105.00
Beta	n/a
RSI	42.86
Earnings Date	Feb 4, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD